Related Experiment Video
Updated: Jan 31, 2026

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
FBXO38 Drives PD-1 to Destruction
Taryn M Serman1, Michaela U Gack1
1Department of Microbiology, The University of Chicago, Chicago, IL 60637, USA.
Abstract:
Aberrant expression of T cell-resident programmed cell death protein-1 (PD-1) is known to promote tumor progression. A recent study (Nature 2018;564:130-135) has now identified the E3 ubiquitin ligase FBXO38 as a crucial regulator of PD-1 protein turnover in T cells, providing a novel mechanism for potential use in cancer immunotherapy.
Insights
Researchers found that FBXO38 controls programmed cell death protein-1 (PD-1) levels in T cells. This discovery offers a new target for cancer immunotherapy by regulating PD-1, which promotes tumor growth.
Area of Science:
- Immunology
- Molecular Biology
- Oncology
Background:
- Aberrant expression of programmed cell death protein-1 (PD-1) on T cells is implicated in tumor progression.
- Understanding the regulation of PD-1 is critical for developing effective cancer immunotherapies.
Purpose of the Study:
- To investigate the molecular mechanisms regulating programmed cell death protein-1 (PD-1) protein stability in T cells.
- To identify novel regulators of PD-1 turnover relevant to cancer immunotherapy.
Main Methods:
- Utilized techniques to study protein turnover and ubiquitination in T cells.
- Investigated the role of E3 ubiquitin ligases in PD-1 regulation.
Main Results:
- Identified the E3 ubiquitin ligase FBXO38 as a key regulator of PD-1 protein turnover.
- Demonstrated that FBXO38 controls the degradation of PD-1 in T cells.
- FBXO38 activity influences PD-1 levels, impacting T cell function.
Conclusions:
- FBXO38 is a novel and crucial regulator of PD-1 protein stability in T cells.
- Targeting FBXO38 presents a potential new strategy for cancer immunotherapy by modulating PD-1 expression.
Related Concept Videos
Non-destructive Tests for Concrete Strength
PD Controller: Design
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
Time-Domain Interpretation of PD Control
Consider the example of control of motor torque. Initially, a positive...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Frequency-Domain Interpretation of PD Control
The proportional control gain, combined with the...

